Jeff Goater, Chief Executive Officer at Surface Oncology, Inc. (SURF), sold 2,500 shares at $12.50 ($31K) on 2021-02-08, disclosed to the SEC on 2021-02-09.
Scheduled sale ($31k) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| SURF | SELL | 2021-02-03 | $27K | — | Filing → |
| SURF | SELL | 2021-01-21 | $65K | — | Filing → |
| SURF | BUY | 2020-02-07 | $16K | — | Filing → |